Major study aims to reduce painful liver biopsies with simple scans

NCT ID NCT06986447

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: HRI-MAIL-NIT Source: ClinicalTrials.gov ↗

First seen Apr 16, 2026 · Last updated May 04, 2026 · Updated 1 time

Summary

This study follows 1,689 adults with fatty liver disease (MASLD) or a related condition with alcohol use (MetALD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression. Researchers hope these scans can replace liver biopsies in future clinical trials and routine care. The study also aims to better understand how MetALD progresses over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Arizona Liver Health

    Chandler, Arizona, 85224, United States

  • Arizona Liver Health

    Peoria, Arizona, 85381, United States

  • Arizona Liver Health

    Tucson, Arizona, 85712, United States

  • CRIOH

    Westlake, Ohio, 44145, United States

  • Houston Research Institute - Dairy Ashford

    Houston, Texas, 77079, United States

  • Houston Research Institute - Medical Center

    Houston, Texas, 77030, United States

  • Houston Research Institute - Pasadena

    Pasadena, Texas, 77505, United States

  • Houston Research Institute - Sugar Land

    Sugar Land, Texas, 77478, United States

Conditions

Explore the condition pages connected to this study.